Sign In
Buy CHEOY
$39.80
-0.180 (-0.450%)
At Close: Jun 22, 2026
Cochlear CEO on tariffs: 'Watch and wait' to see what happens
04:00am, Friday, 14'th Feb 2025
Dig Howitt, CEO and President of Cochlear, discusses the company's half-year earnings, potential impact of tariffs on the business, and the plunge in the company's share price.
Australia's Cochlear faces worst day in 5 years on weak earnings, forecast
08:27pm, Thursday, 13'th Feb 2025
Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at th
Cochlear Limited (CHEOF) Q2 2025 Earnings Call Transcript
07:27pm, Thursday, 13'th Feb 2025
Cochlear Limited (OTCPK:CHEOF) Q2 2025 Earnings Conference Call February 13, 2025 6:00 PM ET Company Participants Dig Howitt - President & Chief Executive Officer Stu Sayers - President of Asia Pacifi
Develop Investment Strategies by Identifying the Key Market Segments Expected to Register Strong Growth Develop Investment Strategies by Identifying the Key Market Segments Expected to Register Strong
The global cochlear implants market is witnessing substantial growth, fueled by the increasing prevalence of hearing loss, advancements in implant technology, and supportive government initiatives. Ma
Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
09:25am, Tuesday, 12'th Nov 2024
Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear implant
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
09:25am, Friday, 08'th Nov 2024
WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, tod
Healthy Aging Month | Daughter helps father win back his livelihood with cochlear implant
10:57am, Monday, 16'th Sep 2024
LONE TREE, Colo. , Sept. 16, 2024 /PRNewswire/ -- This healthy aging month, Cochlear, the global leader in implantable hearing solutions, is highlighting the Crosby family, who are a great example of
New Strong Sell Stocks for September 11th
08:01am, Wednesday, 11'th Sep 2024
B, CNMD and CHEOY have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2024.
Cochlear CEO: targeting 'around 10%' revenue growth per year
08:30am, Thursday, 15'th Aug 2024
Dig Howitt, CEO and President of Cochlear, says that the company is focused on "raising awareness and referrals" to increase the market for hearing implants.
Cochlear Limited (CHEOF) Q4 2024 Earnings Call Transcript
12:50am, Thursday, 15'th Aug 2024
Cochlear Limited (OTCPK:CHEOF) Q4 2024 Earnings Conference Call August 14, 2024 8:00 PM ET Company Participants Dig Howitt - President and CEO Stu Sayers - Chief Financial Officer Conference Call Part
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cochlear Implants Market Size, Share & Trends Analysis Report by Age Group (Adult, Pediatric), End-use (Hospitals, Clinics), Region, and Segment For
What Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock
01:01pm, Wednesday, 17'th Jul 2024
CochLear Ltd. Unsponsored ADR (CHEOY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
Australia, Cochlear support Japan programme for child hearing implants
01:04am, Wednesday, 17'th Jul 2024
Hearing impaired children in Japan's coastal city of Shizuoka will from next year be able to listen, learn and speak better thanks to an A$6.5 million ($4.4 million) programme funded by the city and t
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to r
